The University of Texas Health Science Center at San Antonio (UT Health San Antonio) will direct a team of researchers to investigate a novel oral vaccine for chlamydia, the most reported sexually transmitted disease, with funding from the ...
Proceeds from financing to support ongoing clinical development of lead program targeting PVR as well as IND-enabling activities for multiple ADC candidates TEL AVIV, Israel , May 6, 2024 /PRNewswire/ -- Guangzhou-Israel ...
A real-world evidence (RWE) study recently published in Open Forum Infectious Diseases (OFID) examined three consecutive U.S. flu seasons in the United States . The study suggests that cell-based quadrivalent influenza vaccine (QIVc) may ...
TAIPEI , April 30, 2024 /PRNewswire/ -- Foresee Pharmaceuticals (TPEx: 6576), ("Foresee") today announced that the first subject has been dosed in its Phase 1 clinical trial of FP-020 in Australia . The Phase 1 clinical trial is a ...
PITTSBURGH , April 29, 2024 /PRNewswire/ -- PANTHERx® Rare, a leader in rare disease product patient access and support services in the United States, today announced it was selected by X4 Pharmaceuticals, Inc. for the distribution of ...
CHENGDU, China , April 29, 2024 /PRNewswire/ -- Technoderma Medicines, Inc. ("the Company"), a clinical stage biopharmaceutical company, is pleased to report the Company has begun dosing patients in its Phase 2a clinical ...
Unlocking the Power of THCV: Happy Fruit's New Gummies Suppress Appetites and Provide Metabolic Support * OCEANSIDE, Calif. , April 18, 2024 /PRNewswire/ -- Happy Fruit , Â renowned for its delicious and nutritious fruit ...
On behalf of the organizing committee its great pleasure to invite to all attendees of the "41st International Conference on Drug Discovery and Drug Delivery System" taking place on November 28-29 2024 in the enchanting city of Paris France. With ...
LONDON, Ontario, April 15, 2024 (GLOBE NEWSWIRE) -- London Research & Pharmaceuticals has recently publicized data about its lead compound LRP-661 or Cannabidiol sulphate (CBDS), highlighting its safety, efficacy, bioavailability, and ...
Provides MarVax™ Heat Stable Vaccine Seven Years of U.S. Market Exclusivity Upon FDA Approval PRINCETON, N.J. , April 15, 2024 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage ...
The type 2 diabetes and obesity market for GLP-1R agonists is expected to reach $125 billion in 7 major markets by 2033. This estimation has been projected by GlobalData, a leading data and analytics company ( ). Glucagon-like ...
Blood pressure medications significantly elevate the risk of life-threatening bone fractures, as per research by Rutgers Health published in JAMA Internal Medicine. The...
Zydus Lifesciences, an Indian pharmaceutical company, revealed on Saturday that it has obtained the final approval from the US Food and Drug Administration (USFDA) to distribute a generic drug for arthritis and various other ...
Providing rotavirus vaccine to infants in neonatal intensive care units (NICUs) is safe and does not lead to disease outbreaks ( ). Rotaviruses are majorly responsible for diarrheal disease among infants and young children. The vaccine, which ...
Dapagliflozin, a medication prescribed for managing Type 2 diabetes , has demonstrated additional benefits in heart failure conditions. This drug lowers the likelihood of hospitalization due to heart failure and mortality in ...
Subscribe to our Free Newsletters!
Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment.
Full Disclaimer
Advertise with us | Medindia Copyright | Privacy Policy | Terms of Use © All Rights Reserved 1997 - 2024
Careers